Cargando…

The severity of COVID-19 in children on immunosuppressive medication

Detalles Bibliográficos
Autores principales: Marlais, Matko, Wlodkowski, Tanja, Vivarelli, Marina, Pape, Lars, Tönshoff, Burkhard, Schaefer, Franz, Tullus, Kjell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220160/
https://www.ncbi.nlm.nih.gov/pubmed/32411815
http://dx.doi.org/10.1016/S2352-4642(20)30145-0
_version_ 1783533100176769024
author Marlais, Matko
Wlodkowski, Tanja
Vivarelli, Marina
Pape, Lars
Tönshoff, Burkhard
Schaefer, Franz
Tullus, Kjell
author_facet Marlais, Matko
Wlodkowski, Tanja
Vivarelli, Marina
Pape, Lars
Tönshoff, Burkhard
Schaefer, Franz
Tullus, Kjell
author_sort Marlais, Matko
collection PubMed
description
format Online
Article
Text
id pubmed-7220160
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-72201602020-05-14 The severity of COVID-19 in children on immunosuppressive medication Marlais, Matko Wlodkowski, Tanja Vivarelli, Marina Pape, Lars Tönshoff, Burkhard Schaefer, Franz Tullus, Kjell Lancet Child Adolesc Health Article Elsevier Ltd. 2020-07 2020-05-13 /pmc/articles/PMC7220160/ /pubmed/32411815 http://dx.doi.org/10.1016/S2352-4642(20)30145-0 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Marlais, Matko
Wlodkowski, Tanja
Vivarelli, Marina
Pape, Lars
Tönshoff, Burkhard
Schaefer, Franz
Tullus, Kjell
The severity of COVID-19 in children on immunosuppressive medication
title The severity of COVID-19 in children on immunosuppressive medication
title_full The severity of COVID-19 in children on immunosuppressive medication
title_fullStr The severity of COVID-19 in children on immunosuppressive medication
title_full_unstemmed The severity of COVID-19 in children on immunosuppressive medication
title_short The severity of COVID-19 in children on immunosuppressive medication
title_sort severity of covid-19 in children on immunosuppressive medication
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220160/
https://www.ncbi.nlm.nih.gov/pubmed/32411815
http://dx.doi.org/10.1016/S2352-4642(20)30145-0
work_keys_str_mv AT marlaismatko theseverityofcovid19inchildrenonimmunosuppressivemedication
AT wlodkowskitanja theseverityofcovid19inchildrenonimmunosuppressivemedication
AT vivarellimarina theseverityofcovid19inchildrenonimmunosuppressivemedication
AT papelars theseverityofcovid19inchildrenonimmunosuppressivemedication
AT tonshoffburkhard theseverityofcovid19inchildrenonimmunosuppressivemedication
AT schaeferfranz theseverityofcovid19inchildrenonimmunosuppressivemedication
AT tulluskjell theseverityofcovid19inchildrenonimmunosuppressivemedication
AT marlaismatko severityofcovid19inchildrenonimmunosuppressivemedication
AT wlodkowskitanja severityofcovid19inchildrenonimmunosuppressivemedication
AT vivarellimarina severityofcovid19inchildrenonimmunosuppressivemedication
AT papelars severityofcovid19inchildrenonimmunosuppressivemedication
AT tonshoffburkhard severityofcovid19inchildrenonimmunosuppressivemedication
AT schaeferfranz severityofcovid19inchildrenonimmunosuppressivemedication
AT tulluskjell severityofcovid19inchildrenonimmunosuppressivemedication